New Nordic Healthbrands AB Reports Positive Q2 2025 Performance Amid Market Challenges
New Nordic Healthbrands AB has released its Q2 2025 financial results, showcasing a steady performance despite market challenges. The company observed growth in net sales and improved profitability.
Sammanfattning
New Nordic Healthbrands AB's Q2 2025 results show a 1.5% increase in net sales and improved profitability. The company focuses on innovation and market expansion to drive future growth.
New Nordic Healthbrands AB Reports Positive Q2 2025 Performance Amid Market Challenges
New Nordic Healthbrands AB (publ), a leading provider of dietary supplements and natural health products, has released its financial results for the second quarter of 2025, ending June 30. The company reported a 1.5% increase in net sales, reaching SEK 143.0 million, with a significant improvement in operating and net profit.
Key Performance Indicators (KPIs)
| KPI | Q2 2025 | Q2 2024 |
|---|---|---|
| Net Sales (SEK million) | 143.0 | 140.9 |
| Gross Margin (%) | 64.8 | 65.4 |
| Operating Profit (SEK million) | 3.8 | -1.9 |
| Net Profit (SEK million) | 2.1 | -4.5 |
| Earnings Per Share (SEK) | 0.34 | -0.72 |
| Cash Flow from Operations (SEK million) | 3.5 | 0 |
Year-Over-Year Comparison
| KPI | Change (%) |
|---|---|
| Net Sales | 1.5 |
| Gross Margin | -0.6 |
| Operating Profit | 300.0 |
| Net Profit | 146.7 |
| Earnings Per Share | 147.2 |
| Cash Flow from Operations | 350.0 |
Analysis and Outlook
The company's Q2 2025 performance highlights its resilience in the face of market challenges. The increase in net sales, despite a slight decline in gross margin, indicates strong demand for New Nordic's products. The significant improvement in operating and net profit reflects effective cost management and strategic investments in innovation and market expansion.
CEO Karl Kristian Bergman Jensen noted that revenue growth was primarily driven by strong sales performance of recently launched innovations, particularly in Europe and North America. The company plans to increase marketing investments and expand its distribution network in the second half of 2025 to capitalize on growth opportunities.
New Nordic remains focused on strengthening its position in existing markets while exploring new opportunities through reputable distributors. The company's long-term growth strategy emphasizes product innovation and expanding its product range to meet evolving consumer needs.
Conclusion
New Nordic Healthbrands AB's Q2 2025 results demonstrate a positive trajectory, with improved profitability and strategic growth initiatives. The company's focus on innovation and market expansion positions it well for continued success in the dietary supplement industry.
Källa
Sammanfattning
In the second quarter of 2025, New Nordic Healthbrands AB reported a 1.5% increase in net sales in SEK, amounting to SEK 143.0 million, with a 7.6% increase in local currencies. The gross margin decreased slightly to 64.8%, while operating profit improved to SEK 3.8 million. Net profit after tax rose to SEK 2.1 million, and cash flow from operating activities was SEK 3.5 million. For the first half of 2025, net sales grew by 5.8% in SEK to SEK 286.8 million, with a 9.0% increase in local currencies. The gross margin increased to 64.7%, and operating profit improved to SEK 8.7 million. Net profit after tax was SEK 4.8 million, with cash flow from operating activities at -SEK 2.8 million. CEO Karl Kristian Bergman Jensen highlighted positive revenue and earnings development, driven by strong sales of new innovations. In the Nordics, revenue was unchanged, but challenges arose due to the bankruptcy of Life. Europe and Central Asia saw strong growth, while North America experienced high growth initially, which slowed in the second quarter. Sales declined in other regions, notably in Vietnam and China. Investment markets like Australia, Switzerland, and Spain showed growth. Despite challenges, New Nordic remains focused on strengthening its gross margin and cost control. The company aims to expand its market presence and product range, capitalizing on the growing demand for dietary supplements. The company is not planning to enter new markets independently but is in talks with distributors in new countries. The long-term growth strategy emphasizes innovation and expanding sales of best-selling products.
